0001883850-22-000054.txt : 20220808 0001883850-22-000054.hdr.sgml : 20220808 20220808161230 ACCESSION NUMBER: 0001883850-22-000054 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220804 FILED AS OF DATE: 20220808 DATE AS OF CHANGE: 20220808 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: RYAN ARTHUR F CENTRAL INDEX KEY: 0001187443 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19034 FILM NUMBER: 221144500 MAIL ADDRESS: STREET 1: CITIZENS FINANCIAL GROUP, INC STREET 2: 600 WASHINGTON BOULEVARD CITY: STAMFORD STATE: CT ZIP: 06901 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: REGENERON PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0000872589 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 133444607 STATE OF INCORPORATION: NY FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 777 OLD SAW MILL RIVER ROAD CITY: TARRYTOWN STATE: NY ZIP: 10591 BUSINESS PHONE: 9148477000 MAIL ADDRESS: STREET 1: 777 OLD SAW MILL RIVER ROAD CITY: TARRYTOWN STATE: NY ZIP: 10591 FORMER COMPANY: FORMER CONFORMED NAME: REGENERON PHARMACEUTICALS INC DATE OF NAME CHANGE: 19930328 4 1 edgardoc.xml PRIMARY DOCUMENT X0306 4 2022-08-04 0 0000872589 REGENERON PHARMACEUTICALS, INC. REGN 0001187443 RYAN ARTHUR F 777 OLD SAW MILL RIVER ROAD TARRYTOWN NY 10591 1 0 0 0 Common Stock 2022-08-04 5 G 0 2500 0.0 D 19682 D Common Stock 2022-08-04 4 M 0 3613 482.68 A 23295 D Common Stock 2022-08-04 4 S 0 4887 620.85 D 18408 D Common Stock 2022-08-04 4 M 0 4361 374.12 A 22769 D Common Stock 2022-08-04 4 S 0 4156 621.54 D 18613 D Common Stock 2022-08-04 4 M 0 2479 380.95 A 21092 D Common Stock 2022-08-04 4 S 0 1410 622.06 D 19682 D Non-Qualified Stock Option (right to buy) 374.12 2022-08-04 4 M 0 4361 0.0 D 2030-01-02 Common Stock 4361 0 D Non-Qualified Stock Option (right to buy) 380.95 2022-08-04 4 M 0 2479 0.0 D 2028-01-02 Common Stock 2479 0 D Non-Qualified Stock Option (right to buy) 482.68 2022-08-04 4 M 0 3613 0.0 D 2031-01-04 Common Stock 3613 0 D Represents volume-weighted average price of sales of 4,887 shares of Company stock on August 4, 2022 at prices ranging from $620.16 to $620.97. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 4, 2022 at each separate price. Represents volume-weighted average price of sales of 4,156 shares of Company stock on August 4, 2022 at prices ranging from $621.00 to $621.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 4, 2022 at each separate price. Represents volume-weighted average price of sales of 1,410 shares of Company stock on August 4, 2022 at prices ranging from $622.00 to $622.17. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 4, 2022 at each separate price. On the date of the Company's first annual meeting of shareholders following the date of grant, a portion of these stock options equal to the portion of one year that has passed from the date of grant shall then become exercisable, and the remainder shall become exercisable on the first anniversary of the date of grant. The stock option becomes exercisable in three equal annual installments, commencing one year after the date of grant. /s/**Arthur F. Ryan 2022-08-08